KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Cash & Equivalents (2016 - 2025)

Hologic's Cash & Equivalents history spans 17 years, with the latest figure at $2.0 billion for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 9.29% year-over-year to $2.0 billion; the TTM value through Sep 2025 reached $2.0 billion, down 9.29%, while the annual FY2025 figure was $2.0 billion, 9.29% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $2.0 billion at Hologic, up from $1.7 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.7 billion in Q3 2023 and bottomed at $816.4 million in Q1 2021.
  • The 5-year median for Cash & Equivalents is $2.1 billion (2024), against an average of $1.9 billion.
  • The largest annual shift saw Cash & Equivalents surged 187.01% in 2022 before it decreased 28.86% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $1.4 billion in 2021, then skyrocketed by 71.83% to $2.4 billion in 2022, then dropped by 20.86% to $1.9 billion in 2023, then dropped by 7.76% to $1.8 billion in 2024, then rose by 9.95% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Cash & Equivalents are $2.0 billion (Q3 2025), $1.7 billion (Q2 2025), and $1.8 billion (Q4 2024).